Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

4-Cyano-4-Phenylpiperidine Hydrochloride

    • Product Name 4-Cyano-4-Phenylpiperidine Hydrochloride
    • Alias CPP HCl
    • Einecs 810-716-1
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    466106

    Product Name 4-Cyano-4-Phenylpiperidine Hydrochloride
    Cas Number 40054-69-1
    Molecular Formula C12H13N2·HCl
    Molecular Weight 220.71 g/mol
    Appearance White to off-white solid
    Melting Point 170-175°C (decomposes)
    Solubility Soluble in water
    Smiles C1CC(N(CC1)(C#N)C2=CC=CC=C2)Cl
    Storage Conditions Store at 2-8°C, protected from light and moisture
    Purity Typically ≥98%
    Synonyms 4-Cyano-4-phenylpiperidine hydrochloride, 4-CN-PP HCl

    As an accredited 4-Cyano-4-Phenylpiperidine Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The 25g package contains 4-Cyano-4-Phenylpiperidine Hydrochloride in a sealed amber glass bottle with tamper-evident cap and label.
    Shipping 4-Cyano-4-Phenylpiperidine Hydrochloride is shipped in tightly sealed, chemically resistant containers to prevent moisture and air exposure. The package is labeled according to regulatory guidelines for hazardous chemicals, including all necessary safety information. Shipping follows local and international transport regulations, ensuring the compound remains stable and secure during transit.
    Storage Store 4-Cyano-4-Phenylpiperidine Hydrochloride in a tightly sealed container in a cool, dry, and well-ventilated area, away from moisture, heat, and direct sunlight. Keep it separated from incompatible substances such as strong oxidizers. Ensure the storage area is clearly labeled and access is restricted to trained personnel. Handle under a chemical fume hood when possible.
    Application of 4-Cyano-4-Phenylpiperidine Hydrochloride

    Applications of 4-Cyano-4-Phenylpiperidine Hydrochloride in Industrial Manufacturing

    4-Cyano-4-Phenylpiperidine Hydrochloride serves as a key intermediate in several specialized chemical synthesis processes across pharmaceutical and fine chemical sectors. As a primary manufacturing source, we supply this raw material for use in controlled, high-grade downstream industries that demand strict regulatory compliance and tailored integration into production processes.

    1. Active Pharmaceutical Ingredient (API) Synthesis for Central Nervous System (CNS) Agents

    Leading pharmaceutical manufacturers incorporate this compound as an intermediate when developing certain CNS-targeting APIs. The strict quality specifications demand full traceability and validated batch records. Our material meets European, US, and Japanese pharmacopeias for regulated drug synthesis. Downstream processes require accurate stoichiometry and in-line quality controls during condensation and amination steps.

    Industry compliance standards

    • Current Good Manufacturing Practice (cGMP, ICH Q7)
    • European Pharmacopoeia (Ph. Eur.)
    • United States Pharmacopeia (USP)
    • Japanese Pharmacopoeia (JP)
    • ICH Trace Impurity Guidelines

    Typical usage ratio

    • Used as a defined intermediate, typically 1.0 to 1.5 molar equivalents relative to the target active scaffold. Ratios may adjust in response to process scale and impurity control requirements.

    Downstream process integration

    • Introduced after primary amination but before cyclization or further derivatization steps. Batch addition under inert atmosphere to prevent degradation. Integrated with reaction monitoring via HPLC or NMR for intermediate validation.

    Final product types

    • Prescription CNS drugs including dopamine receptor agonists
    • Experimental compounds for neuropsychiatric research
    • Clinical pipeline molecules targeting central nervous receptors
    • Reference standards for quality control laboratories

    2. Fine Chemical Synthesis for Custom Chiral Building Blocks

    Custom fine chemical suppliers utilize this raw material for assembling high-value chiral intermediates adopted in enantioselective syntheses. Producers conduct controlled hydrogenation or configuration-specific functionalization to deliver building blocks for advanced pharmaceutical and agrochemical libraries. Precision in impurity removal and isomer control is critical for downstream customer acceptance.

    Industry compliance standards

    • ISO 9001 certified production
    • REACH registration (EU)
    • Custom specification certificates (in-house QC)
    • Hazardous Substances Regulations (China, EU, North America)

    Typical usage ratio

    • Applied at 0.8 to 1.2 molar equivalents, matching stoichiometry to the intended chiral transformation. Fine-tuned based on targeted stereochemistry and downstream yield optimization.

    Downstream process integration

    • Added as the primary amine or nitrile component in asymmetric hydrogenation or organometallic catalyzed cascades. Timing and temperature control maintain enantioselectivity. Post-reaction, purification steps include phase transfer or preparative chromatography.

    Final product types

    • Chiral catalysts for pharmaceutical synthesis
    • Custom ligands and stereoisomeric frameworks
    • High-purity fine chemical libraries for discovery chemistry
    • Non-commercial research intermediates

    3. Research and Development of Novel Psychoactive Substance (NPS) Libraries

    Academic and commercial R&D programs incorporate this material in the early-stage diversification and SAR (structure-activity relationship) studies for NPS candidates. Controlled handling procedures support compliance with national safety and security regulations. Material audit trails and purity monitoring underpin its effective use in exploratory compound design.

    Industry compliance standards

    • DEA List I/II precursor registration (US)
    • Controlled Substances Act (where applicable)
    • Laboratory Safety Standard ISO/IEC 17025
    • Material Transfer Agreements for academic/industrial R&D

    Typical usage ratio

    • Variable 0.5 to 2.0 molar equivalents, dependent on target scaffold and SAR branching strategy. Research formulations may run small-scale at high excess.

    Downstream process integration

    • Introduced at initial synthesis or late-stage diversification. Integrated with parallel synthesis platforms or combinatorial chemistry arrays. Analytical verification by LC-MS and NMR required after each batch.

    Final product types

    • Psychoactive research compounds for pharmacology studies
    • SAR libraries advancing NPS regulation and forensic detection
    • Non-clinical experimental standards for lab testing
    • Reference samples for analytical method development

    4. Precursor for Custom Peptide and Alkaloid Analogues

    Specialty contract manufacturers use this raw material as a modular precursor for certain synthetic peptide and alkaloid analogues. It enables side-chain modification or ring-closure steps during late-phase process development. Tight control of input quality and batch homogeneity supports peptide/alkaloid purity and specification adherence for diagnostic and therapeutic candidates.

    Industry compliance standards

    • ISO 13485 for diagnostic intermediates
    • GMP guidelines for clinical trial supply (where classified as API precursor)
    • Food and Drug Administration (FDA) process validation (US)
    • European Medicines Agency (EMA) IMP guidelines

    Typical usage ratio

    • Integrated at 0.7 to 1.3 equivalents according to peptide chain length or alkaloid complexity. Ratio set in process development and scale-up trials.

    Downstream process integration

    • Added post-solid-phase peptide assembly for side-chain cyclization or pre-alkaloid skeleton assembly. Requires controlled addition and temperature profiling. Work-up involves isolation and preparative purification for clinical candidates.

    Final product types

    • Peptide conjugates for immunodiagnostics
    • Alkaloid-based drug analogues for preclinical evaluation
    • Lead structures for biopharmaceutical pipelines
    • Medical research grade peptide intermediates
    Free Quote

    Competitive 4-Cyano-4-Phenylpiperidine Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    4-Cyano-4-Phenylpiperidine Hydrochloride: Direct from the Manufacturing Floor

    A Closer Look at Our Proven 4-Cyano-4-Phenylpiperidine Hydrochloride

    We have spent years refining the synthesis of 4-Cyano-4-Phenylpiperidine Hydrochloride, often known simply as 4-CPP HCl. Manufacturing starts with securing high-purity starting materials—an approach we don’t compromise. Our teams operate with a clear focus on consistent, reproducible chemistry because we know every downstream application counts on reliability. Output follows a strict protocol to yield the hydrochloride salt form, which allows for excellent stability under normal conditions. This is a direct outcome of hands-on chemical process engineering and diligent oversight throughout every batch.

    The finished product typically appears as a solid crystalline powder, easily managed in production suites or lab environments. Our standard offering covers a range of batch scales from a few hundred grams up to multi-kilo lots, with each batch undergoing rigorous HPLC and NMR analysis to confirm specifications. We don’t stop at one-size-fits-all. Insight from regular customer feedback has helped shape both the quality control and the available packaging sizes, narrowing margins for error.

    Why the Right Grade Matters

    4-CPP HCl carries real value for both pharmaceutical research and specialty synthesis work. More than once, partners have reported issues with inconsistent quality from third-party resellers. We maintain direct oversight, all in-house, so no mystery steps or corners cut. We stand behind our ability to offer batch-specific Certificates of Analysis and back it up with documented manufacturing traceability. This allows research teams to move forward without hesitation, especially in critical or regulated environments.

    The hydrochloride salt stands apart from base or other salt forms through its improved handling characteristics. There’s greater solubility in polar solvents, less risk of degradation over short-term storage, and a crystalline structure that facilitates straightforward weighing and transfer in the lab. Several clients have told us plain 4-CPP is more troublesome to standardize; the hydrochloride variant settles that concern.

    Our own process reflects decades of technical troubleshooting. Minor impurities that sneak past routine synthesis steps can disrupt reactions or study results. In our line, we verify every batch by comparing actual IR/NMR spectra to authenticated references. Most commercial “bulk packs” from resellers gloss over these checks, leading to unpredictable side reactions and unnecessary troubleshooting for end-users. We’ve responded with full transparency, offering analytical raw data with every shipment.

    Engineered Reliability: Meeting Modern R&D Demands

    Researchers often ask whether it’s possible to cut costs by switching to a competitor’s formulation. We’ve seen the downstream chaos that comes with marginally different impurities or moisture content. The theoretical specs on a product sheet often gloss over what matters in a real lab. Our batches show minimal batch-to-batch variation in particle size and residual solvent. Teams designing synthetic APIs or screening new chemical entities stay productive instead of fighting with unexplained assay readings or sluggish dissolutions.

    Lessons from real users shape our releases. One of our pharmaceutical customers faced persistent yield drops until they switched from a loosely sourced product to our tightly controlled material. Turnaround times for their HPLC preps improved, purity margins tightened, and downtime fell. It isn’t only about meeting formal purity requirements; it’s about supplying a batch that behaves the same, shipment after shipment. Statistical tracking of each manufacturing run pinpoints anomalies so we can correct course before a batch leaves the site. Our staff shares insights with researchers to bridge the gap between custom synthesis expectations and actual delivery.

    Standing Apart from Commoditized Supply Chain Options

    A lot of chemical supply in this sector runs through a complicated web of brokers. Each link introduces chances for mishandling—erratic storage temperatures, questionable relabeling, or partial documentation. We hold tight control from pre-cursor acquisition to shipment; every gram leaves under our name, not as a generic label with an unknown journey. We’ve seen laboratories unknowingly run side-by-side comparisons, only to report subtle but definite differences in reaction times or yield when using material sourced from traders.

    Large chemical distributors may promise bulk rates, but they risk breakdowns in traceability and real-time support. With direct manufacturing, we can respond fast to unusual technical queries, drawing on in-house chemists rather than passing questions back and forth through sales layers. Each production run logs storage humidity, temperature, and even minor deviations in the local ambient environment; this builds the context for every batch, tangible proof when there’s ever a question about what’s arriving in your lab.

    Effective Application and Downstream Performance

    Synthetic chemists value 4-CPP HCl’s compatibility with a broad range of organic transformations. For anyone engineering novel piperidine derivatives or exploring the structure-activity landscape, fine control over input chemistry directly pays off. We’ve collaborated with drug discovery groups optimizing CNS-active compounds and worked with process development teams looking to minimize workup steps. Early-stage material can make or break these projects, pushing development timelines months ahead—or setting them back with repeat experiments.

    Some users have experienced solubility inconsistencies choosing poorly characterized salts or off-spec batches. Our hydrochloride is standardized for moisture and particle size, so dissolution in most common research solvents proceeds without delay. This isn’t marketing speak; it’s based on repeat feedback and direct analytic data from collaborating end-users.

    Critical Differences: Not All 4-Cyano-4-Phenylpiperidine Hydrochloride is Equal

    What distinguishes 4-CPP HCl directly from the source? Here are the lessons we’ve learned:

    Some commercial packs skirt close to minimum specs on purity and residual solvents, which can lead to subtle setbacks—a false low reading on an HPLC, sluggish dissolutions, or even batch failures that puzzle analytical chemists. We aim higher. Our target specs run tighter than industry averages, not simply to “clear” them but because we deal with the outcome if they don’t.

    No-Nonsense Manufacturing Processes and What They Mean for You

    Our equipment choices and protocol updates reflect regular reviews based on actual use cases, not just regulatory dictates. Many fine chemicals see process drift over years—cut corners on drying steps, relaxed controls on wash solvents, or outdated analysis checkpoints. We routinely update our SOPs and validate against modern analytical standards. For 4-CPP HCl, that means running impurity profiles and residual solvent checks with each lot, not waiting for a customer alert.

    Our site doesn’t outsource critical reactions. If a synthesis step falls out of spec, we address it on the spot, retracing raw material sources or recalibrating equipment before production resumes. Chemists familiar with unreliable supply chains appreciate this blend of control and accountability; timelines and outcomes improve when they aren’t waiting weeks for a new batch or wrestling with unexplained variations.

    Often, we see companies release “just-in-time” batches for the sake of speed. We prepare modest inventory buffers that allow for immediate response while ensuring each lot shares a common synthesis history. Extensive stability testing verifies that sealed, unopened packs maintain integrity over practical storage periods, supporting project planning without guesswork.

    Real-World Feedback: From Discovery to Pilot Production

    Direct conversations with medicinal and process chemists often underline the single biggest challenge: uncertainty in raw input. Feedback loops with our end-users have guided updates to everything from filtration protocols to lot documentation. For example, a research client studying SAR on substituted piperidines reported that inconsistent salt forms from other suppliers distorted biological readouts. With our uniform HCl batches, experimental results tightened and false negatives disappeared.

    Clients entering pilot-scale trials often highlight batch reproducibility and direct communications with the manufacturing team as key drivers for project success. We have built QA gates and analytical checkpoints informed by lessons on the ground, not just from the desk. Our direct supply model reduces missed deadlines and unexpected surprises.

    Supporting Experience and Reputation in Specialty Chemicals

    Supplying 4-Cyano-4-Phenylpiperidine Hydrochloride direct from production means a commitment to know-how and reputation. Our facility runs with a culture of pride in results and open accountability. Long-standing relationships with both researchers and procurement teams speak to this. Whether supporting medicinal chemistry innovation or advanced process development, our experience in the field drives choices in raw material sourcing and process refinement.

    In each case, feedback creates the next round of process improvements. Our team holds regular sessions to debrief on current challenges—unexpected solubility, shipment solutions, or updates in quality documentation. This tight feedback loop connects the manufacturer—not a faceless supplier—to the scientific progress our clients drive.

    Enhancing Analytical Confidence in High-Stakes Projects

    Reliable chemistry translates into clear data, especially in regulated or high-throughput environments. Quality assurance protocols extend beyond initial synthesis. Batches undergo spot checks for degradation, regular cross-referencing with authenticated standards, and archiving of analytical data for years after shipment.

    We’ve seen more than one project derailed by uncontrolled impurities in intermediate materials. Our batch-specific reports support both regulatory filings and analytical troubleshooting—no waiting for a scattered paper trail. We train our staff to spot minor deviations in appearance or behavior under routine handling, so even subtle variations receive documented attention.

    Practical Solutions to Known Industry Challenges

    Working as the actual producer, we see the problems firsthand. Late deliveries, uncertain traceability, or ambiguous documentation can all derail research programs. To address this, our process runs lean on bureaucracy—prioritizing service and traceability over volume for its own sake. Researchers who have struggled with unpredictable delivery schedules find our direct supply model delivers reliability and clearer working timelines.

    Inquiries from users feed into regular technical updates. Clients can expect clarity up front: documentation support, pre-shipment sample checks, and access to historical batch data. Where project needs evolve, our in-house synthesis capacity allows for timely adjustments—whether preparing a formal DMF, complying with new analytical thresholds, or scaling up for developmental milestones.

    Custom requests lead directly to responsive changes in protocol rather than months-long negotiations with subcontractors. We resolve technical issues collaboratively, course-correcting quickly and documenting process shift rationale. Some of our clients in pilot production credit this close relationship with keeping development cycles on track.

    Choosing Consistency Over Commodity in Specialty Chemicals

    The growing demand for 4-Cyano-4-Phenylpiperidine Hydrochloride reflects the rise in advanced pharmaceutical research and tighter oversight in chemical manufacturing. The temptation to chase low cost can jeopardize years of development work. Each chemical batch supplied from our site draws on hands-on expertise, rigorous quality control, and a commitment to straightforward support.

    We look to maintain these standards for every lot, not just the highest-profile orders. Clients working from bench research to full pilot lines rely on reliable supply, transparent documentation, and direct access to technical resources. This belief comes out of years of practical experience: investing in meaningful oversight pays long-term dividends across the research and development cycle.

    Field-Tested Advantages: Insights from Practical Manufacturing

    Working closely with customers, we’ve seen how direct supply of 4-CPP HCl solves problems caused by variable material or uncertain documentation. Our approach addresses predictable pain points: managing impurity loads, supporting scalable synthesis, and providing consistent technical support. End-users share that reliable raw material translates into smoother scale-ups and fewer late-stage surprises.

    We maintain flexibility in our protocols but do not compromise on analytical depth. Demand shifts, regulatory changes, and evolving project needs drive process reviews and new testing checkpoints. This adaptability provides a margin of safety for both basic and applied research, while keeping core quality standards intact.

    Our direct involvement in the entire production chain—right from the selection of starting materials through to final packing and shipment—stands apart in a landscape crowded with indefinite, repackaged supply. The experience we’ve gained as direct producers, responsible both for the product and the support around it, brings confidence to clients tackling complex R&D and production challenges.

    Partnering with Innovators: Supporting Next-Generation Research and Production

    Being a chemical manufacturer, not just a supplier, means seeing project cycles through—from the first inquiry to final delivery. We know the stakes for pharmaceutical companies racing timelines and academic chemists innovating at the bench. As projects move from basic screening to advanced development, material needs shift and new challenges arise.

    Our production staff work to anticipate those changes, update procedures in real time, and connect with researchers on obstacles and breakthroughs. This cycle of process improvement ensures that problems seen in one project fuel solutions for the next, supporting progress across the chemical and pharmaceutical community.

    As work on 4-Cyano-4-Phenylpiperidine Hydrochloride continues to move science forward, we commit to delivering not just material, but the hands-on support and transparency that turn supply into trusted partnership. Each batch is the end result of oversight, actionable feedback, and technical experience—tools that matter as much as the compound itself.